The Antidote: Taking a Look at “Pharmerging” Markets and the Resurgence in UK Biotech IPOs

Add bookmark

Pharma IQ is proud to bring you the latest edition of The Antidote, the quarterly lifesciences newsletter from Europe’s largest law firm, CMS. This edition focuses on the increasing opportunities in Asia, and the resurgence of the UK biotech IPO.

By CMS

Have Your Say
Rate this feature and give us your feedback in the comments section below

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended